BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 17, 2016
View Archived Issues
Sun Biopharma reports progress on phase I trial of SBP-101
Read More
CASI Pharmaceuticals' phase II trial of ENMD-2076 meets stage I endpoint
Read More
Boehringer Ingelheim Pharma patents aldosterone synthase inhibitors
Read More
Anthera Pharmaceuticals says phase III SOLUTION trial will continue
Read More
Genentech and Constellation Pharmaceuticals disclose TAF1 inhibitors
Read More
Genentech and Constellation Pharmaceuticals present KDM1A inhibitors
Read More
Neurocrine Biosciences describes antiepileptic agents
Read More
Cancer Research UK launches phase I/II trial to evaluate guadecitabine in resistant bladder cancer
Read More
Janssen Research & Development gains FDA breakthrough designation for esketamine
Read More
NSAID class may be repurposed to treat Alzheimer's disease
Read More
Phase III AFFINITY trial of custirsen does not meet the primary endpoint
Read More
Vyriad signs license collaboration with Imanis Life Sciences
Read More
Xycrobe Therapeutics enters research agreement with Johnson & Johnson
Read More
Promising phase III topline results for RBP-6000 monthly depot to treat opioid use disorder
Read More
Trek Therapeutics in-licenses rights to Medivir's MIV-802
Read More
Evgen receives CTA in U.K. for phase II breast cancer trial of SFX-01
Read More
Thalidomide reduces VEGF levels in trial in patients with POEMS syndrome
Read More
Eiger initiates phase II trial of pegylated interferon lambda for chronic HDV infection
Read More
Oncoceutics Pharmaceuticals wins FDA orphan grant for phase II trial of ONC-201
Read More
Japan Tobacco seeks Japanese approval for emtricitabine/tenofovir alafenamide
Read More
Study adds to complexity of nasal flu vaccine picture
Read More
Pilot study explores use of high-dose thyroid hormone to promote remyelination in MS
Read More
Phase II trial explores use of abituzumab in systemic sclerosis-associated interstitial lung disease
Read More
Karus Therapeutics initiates phase I trial of KA-2237 in B-cell lymphoma
Read More